June 10, 2022 CDMRP grant

David Sullivan, MD, Johns Hopkins University receives a 3 year CDMRP grant entitled “A Pharmacokinetic and Pharmacodynamic Immunocompromised Mouse Model of the Human Tick-Borne Disease Babesia microti”   AliquantumRx Inc. announces that David Sullivan, MD, professor JHU and Chairman of the Board at AliquantumRx Inc. has received a 3 year Congressionally Directed Medical Research Program […]